Trichomonas vaginalis: alternative pathway activation of complement.
Serum from adult human donors lysed Trichomonas vaginalis. The lytic effect was eliminated by heat-inactivation of serum (56 degrees C, 30 min). No serum donor exhibited significantly increased antibody against the parasite as measured by indirect immunofluorescence. Treatment of serum with ethylene glycol-bis (B-aminoethyl ether)-N, N-tetraacetic acid to eliminate classical pathway complement activation did not prevent C3 leads to C3i conversion in serum incubated with T. vaginalis. Release of complement products during alternative pathway activation may contribute to pathogenesis of trichomonal vaginitis.
D000328:Adult; D000371:Agglutination; D003167:Complement Activation; D003170:Complement Pathway, Alternative; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007123:Immunoelectrophoresis, Two-Dimensional; D008297:Male; D008875:Middle Aged; D014247:Trichomonas Vaginitis / Q000097:blood / Q000276:immunology*; D014246:Trichomonas vaginalis / Q000276:immunology* / Q000378:metabolism